SI
Silo Pharma, Inc.
SILO · NASDAQ
$1.84 +10.18% (+$0.17)
1M -28.68%
Market Cap $2.08M
P/E Ratio -
Div. Yield -
ROE 81.74%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/S 38.40x
P/B 0.42x
P/E N/A
Growth
16 /100
Declining Rev. growth 0.00%
Book val. growth 15.20%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 474.31%
FCF margin 6,176.84%
Net margin 8,269.53%
Quality
0 /100
Poor ROIC 91.31%
Asset turnover 0.01x
ROE 81.74%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -115.27x
Current ratio 5.36x
Stability
76 /100
Stable Beta 0.75x
Profitable years 0
Rev. volatility 0.00%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SILO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Weisblum
Employees
3
Headquarters
Sarasota
Nadcházející události
02 PRO
Earnings
Upcoming earnings report